Top Markets
Coin of the day
Caris Life Sciences, Inc. Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI
Rang in Aktien #2606
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Aktienkurs
$27.92
Marktkapitalisierung
$7.89B
Veränderung (1 Tag)
6.86%
Veränderung (1 Jahr)
-27.44%
Land
US
Handel Caris Life Sciences, Inc. (CAI)

Kategorie

Kursverlauf für Caris Life Sciences, Inc. (CAI)
Höchster Schlusskurs: $23.26 am 2026-08-01

Niedrigster Schlusskurs: $26.95 am 2025-06-01
Kursverlauf der Aktie von Caris Life Sciences, Inc. von 2025 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -14.94%
2025 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$553.23 42.24%
US
$1.02K 50.35%
NL
$157.70 522.09%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH